Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
CVS Group PLC on Thursday posted a rise in annual profit and revenue as the company benefited from favourable and ‘resilient’ market dynamics in the year.
In the year that ended on June 30, the Norfolk-based veterinary service provider said revenue rose 8.6% to £554.2 million from £510.1 million the year before, while pretax profit climbed 8.8% to £36.0 million from £33.1 million.
CVS noted strong like-for-like sales growth of 8.0% benefiting from favourable market dynamics, and a reduction in costs relating to business combinations, amounting to £4.9 million, down 47% from £9.3 million the year before.
Adjusted earnings before interest, tax, depreciation and amortisation amounted to £107.4 million, up 10% from £97.5 million the year before.
The firm added that demand for its services increased as the pet population continues to grow.
Chief Executive Officer Richard Fairman said: ‘The veterinary market remains resilient, with an increasing pet population providing favourable dynamics and a strong platform for sustainable growth across our integrated services. I'm pleased that we have delivered a strong set of results, with good growth against all of our key financial metrics despite a challenging macro-economic backdrop.’
CVS also increased its final dividend by 7.7% to 7.0 pence per share from 6.5p the prior year.
Looking ahead, CVS reported strong sales and like-for-like growth against the previous year in the first 10 weeks of its new financial year. CVS added that trading was in line with market expectations.
Shares were up 0.7% at 1,621.00 pence each on Thursday morning in London.
Copyright 2022 Alliance News Limited. All Rights Reserved.